Your browser doesn't support javascript.
loading
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.
Han, Suji; Shin, Hyemi; Lee, Jin-Ku; Liu, Zhaoqi; Rabadan, Raul; Lee, Jeongwu; Shin, Jihye; Lee, Cheolju; Yang, Heekyoung; Kim, Donggeon; Kim, Sung Heon; Kim, Jooyeon; Oh, Jeong-Woo; Kong, Doo-Sik; Lee, Jung-Il; Seol, Ho Jun; Choi, Jung Won; Kang, Hyun Ju; Nam, Do-Hyun.
Afiliación
  • Han S; Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
  • Shin H; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.
  • Lee JK; Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
  • Liu Z; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.
  • Rabadan R; Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon, Korea.
  • Lee J; Department of Systems Biology, Columbia University, New York, NY, USA.
  • Shin J; Department of Biomedical Informatics, Columbia University, New York, NY, USA.
  • Lee C; Department of Systems Biology, Columbia University, New York, NY, USA.
  • Yang H; Department of Biomedical Informatics, Columbia University, New York, NY, USA.
  • Kim D; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Kim SH; Center for Theragnosis, BRI, Korea Institute of Science and Technology, Seoul, Korea.
  • Kim J; Center for Theragnosis, BRI, Korea Institute of Science and Technology, Seoul, Korea.
  • Oh JW; Department of Biomolecular Science, University of Science and Technology, Daejeon, Korea.
  • Kong DS; Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
  • Lee JI; Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
  • Seol HJ; Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
  • Choi JW; Department of Anatomy and Cell Biology, Sungkyunkwan University, Seoul, Korea.
  • Kang HJ; Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
  • Nam DH; Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Exp Mol Med ; 51(12): 1-11, 2019 12 06.
Article en En | MEDLINE | ID: mdl-31811117
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Sistema Nervioso Central / Proteínas de Unión al ARN / Glioblastoma / Midkina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Exp Mol Med Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_brain_nervous_system_cancer Asunto principal: Sistema Nervioso Central / Proteínas de Unión al ARN / Glioblastoma / Midkina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Exp Mol Med Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2019 Tipo del documento: Article